Skip to main content
Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
29.83
-1.93 (-6.08%)
Nov 13, 2026, 10:32 AM EST - Market open

Alamar Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
Revenue
114.0574.2125.14
Revenue Growth
353.63%195.17%-
Gross Profit
67.6641.718.61
Operating Income
-48-31.33-49.57
Net Income
-55-29.82-46.27
Earnings Per Share
-1.44-2.59-4.60
EPS Growth
---

Revenue by Geography
Chart
Fiscal Year
TTMFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
United States
72.5845.4214.55
Asia-Pacific
9.555.820.49
Europe, Middle East and Africa (Excluding Germany)
-14.125.65
Germany
-8.314.42
Rest of The World
-0.540.03
Total
114.0574.2125.14

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
Cash & Investments
226.593079.36
Total Debt
42.3541.4733.1
Net Cash (Debt)
184.24-11.4746.26
Net Cash Growth
298.29%--
Net Cash Per Share
4.83-0.993.89

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
Operating Cash Flow
-60.92-53.61-55.21
Capital Expenditures
-7.55-5.37-2.95
Free Cash Flow
-68.47-58.98-58.16
Free Cash Flow Growth
---

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
Gross Margin
59.32%56.20%34.23%
Operating Margin
-42.08%-42.22%-197.15%
Pretax Margin
-47.62%-39.29%-187.18%
Profit Margin
-48.23%-40.18%-184.03%
FCF Margin
-60.03%-79.48%-231.33%